• Home
  • Services
  • Projects
  • Resumé
  • Resources
  • News
  • Contact

Some of the projects PharmaCRO has worked on:

  • Development of a treatment for chronic cough in idiopathic pulmonary fibrosis (IPF)
  • Development of a treatment for advanced stage chronic obstructive pulmonary disease (COPD)
  • Development of a lateral flow immunoassay device (IVD)
  • Development of an inhaler (combination product) for the treatment of asthma and COPD
  • Development of oral controlled release products
  • Development of a combination product for systemic delivery of drugs via the inhalation route
  • Development of an automatic, non-invasive continuous glucose monitoring system
  • Development of a transdermal contraceptive patch

  • Projects

    • Development of a treatment for chronic cough in idiopathic pulmonary fibrosis (IPF)
    • Development of a treatment for advanced stage chronic obstructive pulmonary disease (COPD)
    • Development of a lateral flow immunoassay device (IVD)
    • Development of an inhaler (combination product) for the treatment of asthma and COPD
    • Development of oral controlled release products
    • Development of a combination product for systemic delivery of drugs via the inhalation route
    • Development of an automatic, non-invasive continuous glucose monitoring system
    • Development of a transdermal contraceptive patch
  • Projects Subpages

    • Development of a treatment for chronic cough in idiopathic pulmonary fibrosis (IPF)
    • Development of a treatment for advanced stage chronic obstructive pulmonary disease (COPD)
    • Development of a lateral flow immunoassay device (IVD)
    • Development of an inhaler (combination product) for the treatment of asthma and COPD
    • Development of oral controlled release products
    • Development of a combination product for systemic delivery of drugs via the inhalation route
    • Development of an automatic, non-invasive continuous glucose monitoring system
    • Development of a transdermal contraceptive patch
  • Latest

    • Product Designation by the Office of Combination Products (OCP) – Perils
  • Subscribe

    • RSS Entries RSS
    • RSS Comments RSS

Copyright Pharmacro 2026